• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tim-3介导凋亡细胞的吞噬作用和交叉呈递。

Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation.

作者信息

Nakayama Masafumi, Akiba Hisaya, Takeda Kazuyoshi, Kojima Yuko, Hashiguchi Masaaki, Azuma Miyuki, Yagita Hideo, Okumura Ko

机构信息

Department of Immunology, Biomedical Research Center, Juntendo University School of Medicine, Tokyo, Japan.

出版信息

Blood. 2009 Apr 16;113(16):3821-30. doi: 10.1182/blood-2008-10-185884. Epub 2009 Feb 17.

DOI:10.1182/blood-2008-10-185884
PMID:19224762
Abstract

Phagocytes such as macrophages and dendritic cells (DCs) engulf apoptotic cells to maintain peripheral immune tolerance. However, the mechanism for the recognition of dying cells by phagocytes is not fully understood. Here, we demonstrate that T-cell immunoglobulin mucin-3 (Tim-3) recognizes apoptotic cells through the FG loop in the IgV domain, and is crucial for clearance of apoptotic cells by phagocytes. Whereas Tim-4 is highly expressed on peritoneal resident macrophages, Tim-3 is expressed on peritoneal exudate macrophages, monocytes, and splenic DCs, indicating distinct Tim-mediated phagocytic pathways used by different phagocytes. Furthermore, phagocytosis of apoptotic cells by CD8(+) DCs is inhibited by anti-Tim-3 mAb, resulting in a reduced cross-presentation of dying cell-associated antigens in vitro and in vivo. Administration of anti-Tim-3 as well as anti-Tim-4 mAb induces autoantibody production. These results indicate a crucial role for Tim-3 in phagocytosis of apoptotic cells and cross-presentation, which may be linked to peripheral tolerance.

摘要

巨噬细胞和树突状细胞(DCs)等吞噬细胞吞噬凋亡细胞以维持外周免疫耐受。然而,吞噬细胞识别死亡细胞的机制尚未完全阐明。在此,我们证明T细胞免疫球蛋白粘蛋白-3(Tim-3)通过IgV结构域中的FG环识别凋亡细胞,并且对于吞噬细胞清除凋亡细胞至关重要。虽然Tim-4在腹膜驻留巨噬细胞上高度表达,但Tim-3在腹膜渗出巨噬细胞、单核细胞和脾脏DCs上表达,表明不同吞噬细胞使用不同的Tim介导的吞噬途径。此外,抗Tim-3单克隆抗体抑制CD8(+) DCs对凋亡细胞的吞噬作用,导致体外和体内死亡细胞相关抗原的交叉呈递减少。给予抗Tim-3以及抗Tim-4单克隆抗体可诱导自身抗体产生。这些结果表明Tim-3在凋亡细胞吞噬和交叉呈递中起关键作用,这可能与外周耐受有关。

相似文献

1
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation.Tim-3介导凋亡细胞的吞噬作用和交叉呈递。
Blood. 2009 Apr 16;113(16):3821-30. doi: 10.1182/blood-2008-10-185884. Epub 2009 Feb 17.
2
Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.Tim-3在小鼠急性移植物抗宿主病中对肝脏CD8 + T细胞调节的优先作用。
J Immunol. 2006 Oct 1;177(7):4281-7. doi: 10.4049/jimmunol.177.7.4281.
3
Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages.磷酯酰丝氨酸受体 Tim-4 对于维持常驻腹膜巨噬细胞的体内平衡状态是必需的。
Proc Natl Acad Sci U S A. 2010 May 11;107(19):8712-7. doi: 10.1073/pnas.0910929107. Epub 2010 Apr 26.
4
TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.TIM 基因:一族细胞表面磷脂酰丝氨酸受体,调节固有免疫和适应性免疫。
Immunol Rev. 2010 May;235(1):172-89. doi: 10.1111/j.0105-2896.2010.00903.x.
5
Frontline Science: Tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE.前沿科学:Tim-3介导的系统性红斑狼疮中凋亡细胞的功能失调吞噬作用
J Leukoc Biol. 2017 Dec;102(6):1313-1322. doi: 10.1189/jlb.3HI0117-005RR. Epub 2017 Jul 28.
6
T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells.T 细胞/跨膜、Ig 和粘蛋白-3 等位基因变体可识别不同的磷脂酰丝氨酸并介导凋亡细胞的吞噬作用。
J Immunol. 2010 Feb 15;184(4):1918-30. doi: 10.4049/jimmunol.0903059. Epub 2010 Jan 18.
7
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.TIM-1和TIM-4糖蛋白结合磷脂酰丝氨酸并介导凋亡细胞的摄取。
Immunity. 2007 Dec;27(6):927-40. doi: 10.1016/j.immuni.2007.11.011.
8
Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens.定位于边缘区的新型CD8α⁺树突状细胞亚群负责对细胞相关抗原的耐受性。
J Immunol. 2009 Apr 1;182(7):4127-36. doi: 10.4049/jimmunol.0803364.
9
TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance.TIM-4 糖蛋白通过自噬作用降解垂死的肿瘤细胞,导致抗原呈递减少和免疫耐受增加。
Immunity. 2013 Dec 12;39(6):1070-81. doi: 10.1016/j.immuni.2013.09.014. Epub 2013 Dec 5.
10
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.未成熟树突状细胞通过αvβ5和CD36吞噬凋亡细胞,并将抗原交叉呈递给细胞毒性T淋巴细胞。
J Exp Med. 1998 Oct 5;188(7):1359-68. doi: 10.1084/jem.188.7.1359.

引用本文的文献

1
Advances in the study of TIM3 in myelodysplastic syndrome.骨髓增生异常综合征中TIM3的研究进展
Front Immunol. 2025 Aug 19;16:1647401. doi: 10.3389/fimmu.2025.1647401. eCollection 2025.
2
First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors.抗TIM-3单克隆抗体INCAGN02390用于特定晚期或转移性实体瘤患者的首次人体I期开放标签研究。
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf144.
3
Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.
从分子角度看癌症治疗中使用免疫检查点抑制剂(ICI)和抗血管生成药物的基本原理。
Clin Exp Med. 2025 Jul 8;25(1):238. doi: 10.1007/s10238-025-01751-7.
4
Unraveling the immunomodulatory role of TIM-3 in head and neck squamous cell carcinoma: implications for targeted therapy.解析TIM-3在头颈部鳞状细胞癌中的免疫调节作用:对靶向治疗的启示
Discov Oncol. 2025 May 20;16(1):832. doi: 10.1007/s12672-025-02673-2.
5
TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives.TIM-3与PD-1在癌症免疫治疗中的协同作用:机制与展望。
Mol Biomed. 2025 May 7;6(1):27. doi: 10.1186/s43556-025-00267-6.
6
The role of immune checkpoints PD-1 and CTLA-4 in cardiovascular complications leading to heart failure.免疫检查点蛋白PD-1和CTLA-4在导致心力衰竭的心血管并发症中的作用。
Front Immunol. 2025 Apr 4;16:1561968. doi: 10.3389/fimmu.2025.1561968. eCollection 2025.
7
Immune checkpoint blockade for cancer therapy: current progress and perspectives.用于癌症治疗的免疫检查点阻断:当前进展与展望。
J Zhejiang Univ Sci B. 2025 Mar 13;26(3):203-226. doi: 10.1631/jzus.B2300492.
8
Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies.针对非小细胞肺癌的免疫检查点抑制剂:超越PD-1/PD-L1单克隆抗体
Cancers (Basel). 2025 Mar 6;17(5):906. doi: 10.3390/cancers17050906.
9
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4Foxp3 Regulatory T Cell Immunosuppression.免疫检查点是调节心脑血管疾病和CD4Foxp3调节性T细胞免疫抑制的新治疗靶点。
Int J Drug Discov Pharm. 2024 Dec;3(4). doi: 10.53941/ijddp.2024.100022. Epub 2024 Nov 26.
10
Dendritic cell maturation in cancer.癌症中的树突状细胞成熟
Nat Rev Cancer. 2025 Apr;25(4):225-248. doi: 10.1038/s41568-024-00787-3. Epub 2025 Feb 7.